ZYRTEC cetirizine hydrochloride 10 mg soft capsule blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

cetirizine hydrochloride, Quantity: 10 mg

Commercializzato da:

Johnson & Johnson Pacific Pty Ltd

INN (Nome Internazionale):

cetirizine hydrochloride

Forma farmaceutica:

Capsule, soft

Composizione:

Excipient Ingredients: purified water; glycerol; povidone; macrogol 600; lecithin; Gelatin; medium chain triglycerides; sorbitol; potassium hydroxide; propylene glycol; ethyl acetate; ethanol; isopropyl alcohol; strong ammonia solution; iron oxide black; macrogol 400; polyvinyl acetate phthalate

Via di somministrazione:

Oral

Confezione:

49, 42, 14, 28, 56, 63, 70, 77, 84, 91, 98, 105, 112, 119, 126, 133, 140

Tipo di ricetta:

(S2) Pharmacy Medicine

Indicazioni terapeutiche:

Zyrtec Liquid Capsules are indicated for use in adults and children from 12 years of age for:,1. the relief of symptoms associated with seasonal allergic rhinitis (hay fever) or perennial allergic rhinitis including sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing; and,2. the treatment of uncomplicated skin manifestations of chronic idiopathic urticaria. It significantly reduces the occurrence, severity and duration of hives and markedly reduces pruritus.

Dettagli prodotto:

Visual Identification: An oval colourless to slightly yellow, clear capsule containing a transparent solution printed with a logo C10 in black ink.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2014-11-19